SG11202102818YA - Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness - Google Patents

Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Info

Publication number
SG11202102818YA
SG11202102818YA SG11202102818YA SG11202102818YA SG11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA SG 11202102818Y A SG11202102818Y A SG 11202102818YA
Authority
SG
Singapore
Prior art keywords
dryness
symptoms
treatment
surface damage
ocular surface
Prior art date
Application number
SG11202102818YA
Other languages
English (en)
Inventor
Markus Beier
Daniela Willen
Sonja Krösser
Thomas Schlüter
Original Assignee
Novaliq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh
Publication of SG11202102818YA publication Critical patent/SG11202102818YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202102818YA 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness SG11202102818YA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18196126 2018-09-22
EP18198440 2018-10-03
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (1)

Publication Number Publication Date
SG11202102818YA true SG11202102818YA (en) 2021-04-29

Family

ID=68240699

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202102818YA SG11202102818YA (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Country Status (11)

Country Link
US (1) US20210346313A1 (zh)
EP (1) EP3852734A1 (zh)
JP (1) JP2022500461A (zh)
KR (1) KR20210080388A (zh)
CN (1) CN112739335A (zh)
AU (1) AU2019342426A1 (zh)
CA (1) CA3111873A1 (zh)
IL (1) IL281516A (zh)
PH (1) PH12021550621A1 (zh)
SG (1) SG11202102818YA (zh)
WO (1) WO2020058504A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017329772B2 (en) 2016-09-22 2023-02-02 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
ES2965677T3 (es) 2016-09-23 2024-04-16 Novaliq Gmbh Composiciones oftálmicas que comprenden ciclosporina
KR20200059272A (ko) 2017-09-27 2020-05-28 노바리크 게엠베하 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물
CA3091308A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
EP2335735A1 (en) 2009-12-14 2011-06-22 Novaliq GmbH Pharmaceutical composition for treatment of dry eye syndrome
CN106511322B (zh) 2012-09-12 2021-09-17 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
PL3355990T3 (pl) * 2015-09-30 2019-11-29 Novaliq Gmbh Semifluorowane związki oraz ich kompozycje
AU2017329772B2 (en) * 2016-09-22 2023-02-02 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2019068763A1 (en) * 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8

Also Published As

Publication number Publication date
WO2020058504A1 (en) 2020-03-26
JP2022500461A (ja) 2022-01-04
AU2019342426A1 (en) 2021-05-20
US20210346313A1 (en) 2021-11-11
EP3852734A1 (en) 2021-07-28
IL281516A (en) 2021-04-29
CA3111873A1 (en) 2020-03-26
KR20210080388A (ko) 2021-06-30
CN112739335A (zh) 2021-04-30
PH12021550621A1 (en) 2022-02-14

Similar Documents

Publication Publication Date Title
IL281516A (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
IL278178A (en) Use of pilocarpine hydrochloride to treat eye disorder
PT3399962T (pt) Composição oftálmica para o tratamento da doença do olho seco
EP3463315C0 (en) COMPOSITIONS AND METHODS OF USE OF NINTEDANIB IN THE TREATMENT OF EYE DISEASES WITH ABNORMAL NEOVASCULARIZATION
IL281773A (en) Eye preparation for the treatment of dry eye disease
IL277557A (en) Self-assembling peptidomimetics and peptidomimetics for the treatment of eye diseases
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
IL284344A (en) Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye
IL287802A (en) Preparations and methods for the treatment of eye diseases
EP3668474A4 (en) METHODS OF DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME AND COMPOSITIONS FOR TREATMENT OF A HUMAN EYE
ZA202002991B (en) Methods and compositions for assessing and treating intraocular diseases and disorders
EP3618868A4 (en) METHODS AND COMPOSITIONS FOR TREATING ALLERGIC EYE DISEASES
EP3644966A4 (en) TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS
EP3691654A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES
SG11202012473UA (en) Ophthalmic compositions and methods for the treatment of eye disorders
IL287441A (en) Preparations and methods of use for the treatment of dry eye
EP3538083A4 (en) FORMULATIONS FOR THE TREATMENT OF EYE SURFACE DISEASES AND ASSOCIATED METHODS
ZA202107235B (en) Compositions and methods for treating ocular disease
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
IL280588A (en) Ophthalmic compositions and methods for treating eye problems and skin diseases
LT3897595T (lt) Maistinė oftalmologinė kompozicija, skirta gydyti tinklainės patologijoms su neovaskuliniu komponentu
AU2022202629B2 (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
EP4069220A4 (en) OPHTHALMIC FORMULATIONS FOR THE TREATMENT OF PRESBYOPIA
EP3970751C0 (en) OPHTHALMIC COMPOSITION FOR THE TREATMENT OF CORNEAL EDEMA
SG11202009006WA (en) Polysaccharides for the treatment of ocular conditions